Most people don’t interact with Thermo Fisher Scientific firsthand. Still, the company's tools, services and manufacturing capabilities underpin many of the advances that define modern life, from new medicines and diagnostic tests that keep us healthy, to the materials and semiconductors that power the digital economy.
In this episode of Exceptional Leaders, Morgan Stanley’s Head of Life Science Tools and Diagnostics Research, Kallum Titchmarsh, visits Thermo Fisher's biologics and gene-therapy manufacturing facility in Plainville, Massachusetts, for a conversation with the company’s Chairman and CEO Marc Casper. They discuss how Thermo Fisher helps turn discovery into medicine at every stage, and how AI, automation and a relentless customer focus could accelerate the breakthroughs ahead.
The preceding content was informational only and is not an offer nor a solicitation to purchase or sell any security, commodity, instrument, or fund or to participate in any investment or trading strategy. The appropriateness of a particular investment or strategy will depend on an investor’s individual circumstances and objectives. Morgan Stanley does not render advice on legal or tax and tax accounting matters to clients. Clients should always consult their own legal or tax advisor for information concerning their individual situation.
Opinions expressed by third parties are solely their own. All opinions are subject to change without notice.
©2026 Morgan Stanley, all rights reserved.
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.